E-Therapeutics PLC
LSE:ETX

Watchlist Manager
E-Therapeutics PLC Logo
E-Therapeutics PLC
LSE:ETX
Watchlist
Price: 9 GBX -6.74%
Market Cap: 52.6m GBX

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ETX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ETX Intrinsic Value
Not Available
Base Case Scenario
Compare ETX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ETX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
E-Therapeutics PLC

Current Assets 34m
Cash & Short-Term Investments 31.7m
Receivables 1.8m
Other Current Assets 553k
Non-Current Assets 639k
PP&E 400k
Intangibles 239k
Current Liabilities 1.6m
Accounts Payable 1.3m
Other Current Liabilities 295k
Efficiency

Free Cash Flow Analysis
E-Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
E-Therapeutics PLC

Revenue
475k GBP
Cost of Revenue
0 GBP
Gross Profit
475k GBP
Operating Expenses
-10.7m GBP
Operating Income
-10.2m GBP
Other Expenses
2m GBP
Net Income
-8.3m GBP
Fundamental Scores

ETX Profitability Score
Profitability Due Diligence

E-Therapeutics PLC's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
21/100
Profitability
Score

E-Therapeutics PLC's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ETX Solvency Score
Solvency Due Diligence

E-Therapeutics PLC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

E-Therapeutics PLC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ETX Price Targets Summary
E-Therapeutics PLC

There are no price targets for ETX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

E-Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ETX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y